GIANNITRAPANI, Lydia
 Distribuzione geografica
Continente #
NA - Nord America 16.778
EU - Europa 13.176
AS - Asia 7.174
SA - Sud America 1.119
Continente sconosciuto - Info sul continente non disponibili 840
AF - Africa 244
OC - Oceania 33
Totale 39.364
Nazione #
US - Stati Uniti d'America 16.374
IT - Italia 6.169
SG - Singapore 2.463
RU - Federazione Russa 2.267
CN - Cina 1.786
FI - Finlandia 1.001
HK - Hong Kong 880
BR - Brasile 813
DE - Germania 748
UA - Ucraina 669
VN - Vietnam 664
PL - Polonia 432
GB - Regno Unito 400
FR - Francia 377
IE - Irlanda 331
BD - Bangladesh 257
JP - Giappone 245
CA - Canada 186
NL - Olanda 183
IN - India 172
SE - Svezia 168
KR - Corea 120
RO - Romania 93
TR - Turchia 90
AR - Argentina 80
BE - Belgio 79
MX - Messico 77
CO - Colombia 60
IQ - Iraq 59
ES - Italia 54
EC - Ecuador 48
CI - Costa d'Avorio 47
ID - Indonesia 46
PK - Pakistan 46
VE - Venezuela 46
ZA - Sudafrica 46
AT - Austria 44
IR - Iran 41
UZ - Uzbekistan 34
MY - Malesia 33
MA - Marocco 32
PH - Filippine 30
CR - Costa Rica 29
CL - Cile 28
EG - Egitto 28
NP - Nepal 27
AU - Australia 26
CH - Svizzera 24
DZ - Algeria 24
JM - Giamaica 24
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
TN - Tunisia 20
SA - Arabia Saudita 19
CZ - Repubblica Ceca 18
KZ - Kazakistan 18
GR - Grecia 15
KE - Kenya 15
LB - Libano 15
PE - Perù 15
AL - Albania 14
EE - Estonia 14
HN - Honduras 14
JO - Giordania 14
LT - Lituania 14
RS - Serbia 13
NI - Nicaragua 12
SV - El Salvador 12
PY - Paraguay 11
TH - Thailandia 10
BG - Bulgaria 9
GT - Guatemala 9
DO - Repubblica Dominicana 8
AM - Armenia 7
BO - Bolivia 7
ET - Etiopia 7
EU - Europa 7
NZ - Nuova Zelanda 7
PA - Panama 7
TW - Taiwan 7
UY - Uruguay 7
BH - Bahrain 6
IL - Israele 6
PR - Porto Rico 6
PS - Palestinian Territory 6
PT - Portogallo 6
SN - Senegal 6
TT - Trinidad e Tobago 6
BB - Barbados 5
BY - Bielorussia 5
KG - Kirghizistan 5
DK - Danimarca 4
GE - Georgia 4
HU - Ungheria 4
KH - Cambogia 4
CY - Cipro 3
HR - Croazia 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
Totale 38.473
Città #
Ashburn 2.071
Singapore 1.638
San Jose 1.284
Fairfield 1.241
Chandler 1.002
Woodbridge 663
Hong Kong 651
Houston 626
Wilmington 608
Ann Arbor 518
Seattle 491
Milan 468
Palermo 410
Cambridge 409
Moscow 377
Zgierz 362
Council Bluffs 357
Jacksonville 349
Dublin 327
Rome 313
Beijing 293
Los Angeles 293
New York 283
Des Moines 275
Medford 255
Santa Clara 239
Tokyo 237
Dallas 235
Ho Chi Minh City 221
Frankfurt am Main 196
Nanjing 189
Boardman 172
Princeton 169
Chicago 168
The Dalles 168
Naples 166
Hanoi 161
Lauterbourg 153
Altamura 143
Dearborn 112
Tulsa 98
Lawrence 97
Helsinki 96
San Diego 95
Buffalo 90
Hefei 89
São Paulo 89
Florence 76
Shenyang 73
Brussels 71
Orem 68
Hebei 66
Jinan 65
Turin 65
Venice 63
Nanchang 61
Verona 59
Falls Church 58
Toronto 58
Tianjin 57
Bologna 55
Changsha 55
London 53
Munich 53
Brooklyn 51
Denver 50
Nuremberg 50
Phoenix 50
Abidjan 47
Atlanta 45
Ludwigshafen am Rhein 45
Da Nang 44
Ningbo 42
Catania 41
Jiaxing 41
Chennai 40
Columbus 39
Warsaw 39
Genoa 38
Cagliari 36
Amsterdam 35
Bari 34
Hangzhou 34
Montreal 34
Washington 34
Zhengzhou 33
Brescia 31
Campinas 29
Rio de Janeiro 29
Guangzhou 28
Izmir 28
Johannesburg 28
Napoli 27
Padova 27
Perugia 26
Redwood City 26
Kumar 25
Manchester 25
Paris 25
Salerno 25
Totale 21.284
Nome #
Nodulo epatico ipovascolare: ruolo dell’ecografia nella diagnosi di HCC 4.293
MODIFICAZIONI ECOGRAFICHE DELLA LINFADENOPATIA DELL’ILO EPATICO DOPO ERADICAZIONE DELL’HCV CON DIRECT-ACTING ANTIVIRALS 569
A phenobarbital overdose: a case report 434
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 432
Clinical manifestations and outcome predictors of SARS-COV2 disease (COVID-19): experience of a single center. 415
ALLELIC VARIANTS OF CYP2E1 GENE IN HEPATOCARCINOMA PATIENTS AND IN HEPATIC TUMOR CELL LINES 405
Clinical course and management of acute and chronic viral hepatitis during pregnancy. 334
Ruolo dell'interazione NK/KIR nella storia naturale delle infezioni virali 317
Hepatocellular carcinoma: Comparison of two different periods at the same center 298
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. 288
Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review 287
Low-grade fever: how to distinguish organic from non-organic forms. 278
EFFETTI DELLA TERAPIA CON DIRECT ACTING ANTIVIRALS (DAAS) SUI PARAMETRI ECOGRAFICI DI IPERTENSIONE PORTALE 276
An unusual Erdheim-Chester disease with orbital involvement: A case report 271
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 271
Hemophagocytic syndrome in a patient with disseminated tuberculosis: A case report 271
A key role for abdominal ultrasound examination in "difficult" diagnoses of celiac disease 268
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects 264
The health of irregular and illegal immigrants: analysis of day-hospital admissions in a department of migration medicine 263
Subclinical cardiovascular damage in patients with HCV cirrhosis before and after treatment with direct antiviral agents: a prospective study 262
Effects of Steatosis on Hepatic Hemodynamics in Patients with Metabolic Syndrome 261
Associated Factors and Liver Disease Severity for Decreased Bone Mineral Density in HIV Mono- and HIV/HCV Co-infected Patients 260
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia. 256
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 254
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 253
Nontumorous portal vein thrombosis in liver cirrhosis: Possible role of β-blockers 251
Association Between Single Nucleotide Polymorphisms in the Cyclooxygenase-2, Tumor Necrosis Factor-a, and Vascular Endothelial Growth Factor-A Genes, and Susceptibility to Hepatocellular Carcinoma 248
Genetic determined down regulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 246
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 245
Prospective evaluation of hepatic steatosis in HIV-infected patients with or without hepatitis C virus co-infection 242
Interessamento epatico in corso di febbre bottonosa del Mediterraneo 241
Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases 241
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 241
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis. 239
Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma. 238
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 238
Sex hormones and risk of liver tumor 229
Abdominal US evaluation in celiac disease before and after a gluten-free diet 227
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. 227
Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI 226
The association of variants in PNPLA3 and GRP78 and the risk of developing hepatocellular carcinoma in an Italian population 225
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 223
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: The International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 221
Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study 220
Drammaturgia di un prurito 219
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid 219
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 219
Affidabilità del bright liver nella steatosi epatica in soggetti con ipertransaminasemia criptogenetica e con epatopatia da virus C 218
SCREENING DELL’EPATOCARCINOMA (HCC) NELLA CIRROSI EPATICA (CE): RUOLO DEI PATTERN ECOGRAFICI (US) 218
Il bright liver echopattern come strumento diagnostico non invasivo di steatosi nell'ipertransaminasemia criptogenetica 217
Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report. 217
Leucocyte interferon-alpha for patients with chronic hepatitis C intolerant to other alpha-interferons 216
Osteoporosis risk factors in HIV positive women with osteoporosis: A retrospective analysis 216
Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult 215
PREVALENCE OF LIVER DISEASES IN A POPULATION OF IMMIGRANTS IN SICILY. ANALYSIS OF DAY-HOSPITAL ADMISSIONS IN A DEPARTMENT OF MIGRATION MEDICINE 213
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents 213
Epidemiology, Diagnosis, and Non-Pharmacological Treatment of HCC 212
Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment 212
Association between single nucleotide polymorphisms (SNPs) of IL-6, TNF-alpha and VEGF-A genes, and susceptibility to hepatocellular carcinoma (HCC) 211
COMEPA (COVID-19 Medicina Policlinico Palermo): a study in hospitalized patients. 210
Hepatic expression of cyclooxygenase-2 in non alcoholic fatty liver disease 209
Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C. 209
Circulating levels of molecular adhesion correlate with stage of renal disease and C-reactive protein in chronic kidney disease 209
Liver disease severity and low bone mineral density in HIV mono-infected and HIV/HCV co-infected patients 208
Cyclooxygenase- 2, Tumor Necrosis Factor-α, Vascular Endothelial Growth Factor-A and IL-6 genes SNPs and IL-6 serum levels in liver cirrhosis and hepatocellular carcinoma 208
Association between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample 208
Alteraziioni morfofunzionali vascolari in una popolazione con sindrome metabolica e steatosi epatica ecografica 203
Affidabilità del Bright liver echopattern nella diagnosi di steatosi in pazienti con ipertransaminasemia criptogenetica 202
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 202
Late-onset Sheehan's syndrome presenting with rhabdomyolysis and hyponatremia: a case report. 201
A questionable diagnosis in a woman with drowsiness 201
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. 200
Minor hepatic resection for hepatocellular carcinoma in cirrhotic patients: Kelly clamp crushing resection versus heat coagulative necrosis with bipolar radiofrequency device 197
Two single nucleotide polymorphisms in the MICA gene and sMICA plasma levels are associated with hepatocellular carcinoma development in an Italian population of HCV related liver cirrhosis 197
Optimizing diagnostic approach to drug-induced liver injury 197
IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma 196
Variable Number of Tandem Repeats (VNTR) gene polymorphism of CYP2E1 in patients with pancreatic adenocarcinoma 196
HepaDisk – A new quality of life questionnaire for HCV patients 196
CEUS in the differential diagnosis between biliary sludge, benign lesions and malignant lesions 195
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 193
Affidabilità del bright liver nella diagnosi di steatosi epatica in pazienti con infezione da virus dell'immunodeficienza acquisita (HIV), da virus dell'epatite C (HCV) e coinfezione HCV/HIV: dati preliminari 193
Common polymorphisms in Th1 and Th2 cytokine genes and susceptibility to pancreatic adenocarcinoma 191
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. 189
SURVEILLANCE PROGRAM FOR DIAGNOSIS OF HCC IN LIVER CIRRHOSIS: ROLE OF ULTRASOUND ECHOPATTERNS 188
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 187
VEGFR-2, HSP90 and GRP78/BiP expression and HCC recurrence after Liver Transplantation 187
Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer 186
Distribution of liver disease in a cohort of immigrants in Sicily: analysis of day-hospital admissions in a migration medicine unit 184
Effects of direct-acting antiviral therapy (DAAS) on the ultrasound parameters of portal hypertension 184
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis. 183
Steatosi epatica (SE) e rischio cardiovascolare in una popolazione di pazienti HIV-positivi 183
Waiting-time and quality of care deserved to patients with early stage hepatocellular carcinoma undergoing RFA treatment 182
New landscapes and horizons in hepatocellular carcinoma therapy 180
NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response 180
Disfunzione endoteliale e malattia carotidea in pazienti con bright liver echopattern 179
Utilità dell’ecografia intestinale nei pazienti con malattia celiaca a sierologia negativa 179
Non invasive tools for the diagnosis of liver cirrhosis 179
Long-term follow-up of hepatitis C virus-positive patients with persistently normal serum transaminases 178
GRP78 POLYMORPHISM rs430397 IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN A SOUTHERN ITALIAN POPULATION 175
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 174
Totale 27.381
Categoria #
all - tutte 116.787
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.787


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.631 0 0 0 95 102 137 91 125 286 289 127 379
2022/20233.673 328 476 80 333 306 458 263 527 360 84 232 226
2023/20243.286 169 340 218 293 245 414 279 221 100 396 249 362
2024/20254.708 220 377 294 480 302 230 369 289 337 442 588 780
2025/202612.612 896 338 649 930 1.181 1.839 1.765 1.289 1.015 1.526 540 644
2026/20272.861 577 390 1.631 263 0 0 0 0 0 0 0 0
Totale 39.364